Risk factors for Mycobacterium tuberculosis in US chronic dialysis patients
Klote et al.
Nephrol Dial Transplant 2006;21:3287-3292.
ABSTRACT
| FULL TEXT
The value of tuberculin skin testing in haemodialysis patients
Wauters et al.
Nephrol Dial Transplant 2004;19:433-438.
ABSTRACT
| FULL TEXT
Side-effects of antituberculosis drug treatment in patients with chronic renal failure
Quantrill et al.
Eur Respir J 2002;20:440-443.
ABSTRACT
| FULL TEXT
Peritoneal tuberculosis in patients receiving continuous ambulatory peritoneal dialysis
Quantrill et al.
Nephrol Dial Transplant 2001;16:1024-1027.
ABSTRACT
| FULL TEXT
Resolution of Pleural Effusions
Cohen and Sahn
Chest 2001;119:1547-1562.
FULL TEXT
Benefits of Screening for Latent Mycobacterium tuberculosis Infection
Rose
Arch Intern Med 2000;160:1513-1521.
ABSTRACT
| FULL TEXT
The Effect of Hemodialysis on Cycloserine, Ethionamide, Para-Aminosalicylate, and Clofazimine
Malone et al.
Chest 1999;116:984-990.
ABSTRACT
| FULL TEXT
The Effect of Hemodialysis on Isoniazid, Rifampin, Pyrazinamide, and Ethambutol
MALONE et al.
Am. J. Respir. Crit. Care Med. 1999;159:1580-1584.
ABSTRACT
| FULL TEXT
Mycobacterial Infections in Renal Transplant Recipients: Seven Cases and a Review of the Literature
Lloveras et al.
Arch Intern Med 1982;142:888-892.
ABSTRACT
Tuberculosis in Chronic Renal Failure
Khan et al.
Arch Intern Med 1981;141:1554-1554.
ABSTRACT
Tuberculosis in Chronic Renal Failure
Brandspigel and Mattern
Arch Intern Med 1980;140:1674-1675.
ABSTRACT
Host Defenses and Immunologic Alterations Associated with Chronic Hemodialysis
GOLDBLUM and REED
ANN INTERN MED 1980;93:597-613.
ABSTRACT